During the last session, NuVasive Inc. (NASDAQ:NUVA)’s traded shares were 0.5 million, with the beta value of the company hitting 1.21. At the end of the trading day, the stock’s price was $52.13, reflecting an intraday loss of -4.17% or -$2.27. The 52-week high for the NUVA share is $72.61, that puts it down -39.29 from that peak though still a striking 12.81% gain since the share price plummeted to a 52-week low of $45.45. The company’s market capitalization is $2.68B, and the average trade volume was 792.24K shares over the past three months.
NuVasive Inc. (NUVA) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 2.60. NUVA has a Sell rating from 1 analyst(s) out of 17 analysts who have looked at this stock. 7 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 8 recommend a Buy rating for it. 1 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.49.
3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
NuVasive Inc. (NUVA) registered a -4.17% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.17% in intraday trading to $52.13 this Friday, 01/07/22, hitting a weekly high. The stock’s 5-day price performance is -0.67%, and it has moved by 0.27% in 30 days. Based on these gigs, the overall price performance for the year is -7.44%.
The consensus price target of analysts on Wall Street is $64.73, which implies an increase of 19.47% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $50.00 and $90.00 respectively. As a result, NUVA is trading at a discount of -72.65% off the target high and 4.09% off the low.
NuVasive Inc. (NUVA) estimates and forecasts
Statistics show that NuVasive Inc. has outperformed its competitors in share price, compared to the industry in which it operates. NuVasive Inc. (NUVA) shares have gone down -22.29% during the last six months, with a year-to-date growth rate more than the industry average at 43.90% against 14.30. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -16.90% this quarter and then jump 35.10% in the quarter after that. In the rating firms’ projections, revenue will increase 8.20% compared to the previous financial year.
Revenue for the current quarter is expected to be $299.42 million as predicted by 15 analyst(s). Meanwhile, a consensus of 8 analyst(s) estimates revenue growth to $289 million by the end of Mar 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $291.81 million and $261.77 million respectively. In this case, analysts expect current quarter sales to grow by 2.60% and then jump by 10.40% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -20.80%. While earnings are projected to return -158.90% in 2022, the next five years will return 25.14% per annum.
NuVasive Inc. is due to release its next quarterly earnings between February 23 and February 28. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
NuVasive Inc. (NASDAQ:NUVA)’s Major holders
NuVasive Inc. insiders own 0.62% of total outstanding shares while institutional holders control 101.39%, with the float percentage being 102.02%. Blackrock Inc. is the largest shareholder of the company, while 349 institutions own stock in it. As of Sep 29, 2021, the company held over 5.96 million shares (or 11.52% of all shares), a total value of $356.77 million in shares.
The next largest institutional holding, with 5.0 million shares, is of Vanguard Group, Inc. (The)’s that is approximately 9.67% of outstanding shares. At the market price on Sep 29, 2021, these shares were valued at $299.29 million.
Also, the Mutual Funds coming in first place with the largest holdings of NuVasive Inc. (NUVA) shares are Vanguard Total Stock Market Index Fund and iShares Core S&P Midcap ETF. Data provided on Sep 29, 2021 indicates that Vanguard Total Stock Market Index Fund owns about 1.47 million shares. This amounts to just over 2.83 percent of the company’s overall shares, with a $87.76 million market value. The same data shows that the other fund manager holds slightly less at 1.39 million, or about 2.69% of the stock, which is worth about $74.28 million.